logoJobsCompanies
chatpopShare Your Feedback
Shennon Biotechnologies

Shennon Biotechnologies

Biotechnology
Life Science
11-50 employees
In logocb logo
Analyze, understand & manipulate immune cells on the single cell level to develop better treatments for human diseases
Founded in 2021
San Francisco, California, USA
11-50 employees
https://www.shennonbio.com/
Funding
Early Stage
Current Stage
$13M
Recent Funding
$13M
Total Funding
Leadership Team
TomJ
Li Sun, PhD
Founder/CEO
In logo
Recent News
DCVC leads $13 million seed funding for ShennonBio — revolutionizing immunotherapy through immune cell profiling at unprecedented accuracy, speed
DCVC
Microfluidic devices for high throughput screening of cell-cell interactions
Google Patent
Digital health news, funding round up in the prior week; March 20, 2023
VatorNews
City
Experience Level
Work Model
loading